NASDAQ:MATK
$31.49
- 0.01
Feb 25, 2011
4:00 PM ET
Martek Biosciences Corporation
Investors
Home
About Martek
Healthcare Professionals
Investors
Press Releases
Events & Presentations
Management
Financial Information
SEC Filings
Quarterly Results
Annual Reports & Proxy
Investor FAQs
Products & Services
Home
•
Investors
Investor Relations
Martek is now a wholly owned subsidiary of
DSM
.
Read the announcement
here
